Methamphetamine-Evoked Depression of GABA B Receptor Signaling in GABA Neurons of the VTA

Neuron

Volumn 73, Issue 5, 2012, Pages 978-989

  Padgett, Claire L ^a   Lalive, Arnaud L ^b   Tan, Kelly R ^b   Terunuma, Miho ^d   Munoz, Michaelanne B ^a   Pangalos, Menelas N ^h   Martínez Hernández, José ^f   Watanabe, Masahiko ^g   Moss, Stephen J ^d,e   Luján, Rafael ^f   Lüscher, Christian ^b,c   Slesinger, Paul A ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f Universidad Castilla La Mancha   (Spain)

^g HOKKAIDO UNIVERSITY   (Japan)

^h ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; BACLOFEN; COCAINE; DOPAMINE; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; METHAMPHETAMINE; PHOSPHOPROTEIN PHOSPHATASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GABAERGIC SYSTEM; GABAERGIC TRANSMISSION; IMMUNOELECTRON MICROSCOPY; INTERNALIZATION; MALE; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; POTASSIUM CURRENT; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; VENTRAL TEGMENTUM;

ACTION POTENTIALS; ANIMALS; ANIMALS, NEWBORN; BACLOFEN; BACTERIAL PROTEINS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE; DOPAMINE AGENTS; DOWN-REGULATION; DRUG INTERACTIONS; FEMALE; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; GABA-B RECEPTOR AGONISTS; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; GREEN FLUORESCENT PROTEINS; HOMEODOMAIN PROTEINS; INHIBITORY POSTSYNAPTIC POTENTIALS; LUMINESCENT PROTEINS; MALE; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, IMMUNOELECTRON; NEURONS; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHORYLATION; RECEPTORS, GABA-A; RHODOPSIN; TRANSCRIPTION FACTORS; VENTRAL TEGMENTAL AREA;

EID: 84858042525     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2011.12.031     Document Type: Article

References (75)

1. Aguado C., Colón J., Ciruela F., Schlaudraff F., Cabañero M.J., Perry C., Watanabe M., Liss B., Wickman K., Luján R. Cell type-specific subunit composition of G protein-gated potassium channels in the cerebellum. J. Neurochem. 2008, 105:497-511.
2. Argilli E., Sibley D.R., Malenka R.C., England P.M., Bonci A. Mechanism and time course of cocaine-induced long-term potentiation in the ventral tegmental area. J. Neurosci. 2008, 28:9092-9100.
3. Arora D., Hearing M., Haluk D.M., Mirkovic K., Fajardo-Serrano A., Wessendorf M.W., Watanabe M., Luján R., Wickman K. Acute cocaine exposure weakens GABA(B) receptor-dependent G-protein-gated inwardly rectifying K+ signaling in dopamine neurons of the ventral tegmental area. J. Neurosci. 2011, 31:12251-12257.
4. Beckstead M.J., Grandy D.K., Wickman K., Williams J.T. Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons. Neuron 2004, 42:939-946.
5. Bellone C., Lüscher C. Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGluR-dependent long-term depression. Nat. Neurosci. 2006, 9:636-641.
6. Bonci A., Williams J.T. A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine. Neuron 1996, 16:631-639.
7. Borgland S.L., Malenka R.C., Bonci A. Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats. J. Neurosci. 2004, 24:7482-7490.
8. Borgland S.L., Taha S.A., Sarti F., Fields H.L., Bonci A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 2006, 49:589-601.
9. 2 muscarinic receptors enhances muscarinic signaling. J. Neurosci. 2009, 29:15796-15809.
10. Brown M.T., Bellone C., Mameli M., Labouèbe G., Bocklisch C., Balland B., Dahan L., Luján R., Deisseroth K., Lüscher C. Drug-driven AMPA receptor redistribution mimicked by selective dopamine neuron stimulation. PLoS ONE 2010, 5:e15870.
11. Caine S.B., Thomsen M., Gabriel K.I., Berkowitz J.S., Gold L.H., Koob G.F., Tonegawa S., Zhang J., Xu M. Lack of self-administration of cocaine in dopamine D1 receptor knock-out mice. J. Neurosci. 2007, 27:13140-13150.
12. Chung H.J., Qian X., Ehlers M., Jan Y.N., Jan L.Y. Neuronal activity regulates phosphorylation-dependent surface delivery of G protein-activated inwardly rectifying potassium channels. Proc. Natl. Acad. Sci. USA 2009, 106:629-634.
13. Clancy S.M., Boyer S.B., Slesinger P.A. Coregulation of natively expressed pertussis toxin-sensitive muscarinic receptors with G-protein-activated potassium channels. J. Neurosci. 2007, 27:6388-6399.
14. Cooper D.C. The significance of action potential bursting in the brain reward circuit. Neurochem. Int. 2002, 41:333-340.
15. Couve A., Kittler J.T., Uren J.M., Calver A.R., Pangalos M.N., Walsh F.S., Moss S.J. Association of GABA(B) receptors and members of the 14-3-3 family of signaling proteins. Mol. Cell. Neurosci. 2001, 17:317-328.
16. B) receptor-effector coupling. Nat. Neurosci. 2002, 5:415-424.
17. B) receptor agonists on the mesolimbic dopamine system. Nat. Neurosci. 2004, 7:153-159.
18. Cruz H.G., Berton F., Sollini M., Blanchet C., Pravetoni M., Wickman K., Lüscher C. Absence and rescue of morphine withdrawal in GIRK/Kir3 knock-out mice. J. Neurosci. 2008, 28:4069-4077.
19. Dobbs L.K., Mark G.P. Comparison of systemic and local methamphetamine treatment on acetylcholine and dopamine levels in the ventral tegmental area in the mouse. Neuroscience 2008, 156:700-711.
20. Dobi A., Margolis E.B., Wang H.L., Harvey B.K., Morales M. Glutamatergic and nonglutamatergic neurons of the ventral tegmental area establish local synaptic contacts with dopaminergic and nondopaminergic neurons. J. Neurosci. 2010, 30:218-229.
21. Erhardt S., Mathé J.M., Chergui K., Engberg G., Svensson T.H. GABA(B) receptor-mediated modulation of the firing pattern of ventral tegmental area dopamine neurons in vivo. Naunyn Schmiedebergs Arch. Pharmacol. 2002, 365:173-180.
22. Fairfax B.P., Pitcher J.A., Scott M.G.H., Calver A.R., Pangalos M.N., Moss S.J., Couve A. Phosphorylation and chronic agonist treatment atypically modulate GABAB receptor cell surface stability. J. Biol. Chem. 2004, 279:12565-12573.
23. B receptors with Kir3 channels and regulators of G protein signalling (RGS4) proteins. J. Physiol. 2007, 580:51-65.
24. Fukushima S., Shen H., Hata H., Ohara A., Ohmi K., Ikeda K., Numachi Y., Kobayashi H., Hall F.S., Uhl G.R., Sora I. Methamphetamine-induced locomotor activity and sensitization in dopamine transporter and vesicular monoamine transporter 2 double mutant mice. Psychopharmacology (Berl.) 2007, 193:55-62.
25. Giorgetti M., Hotsenpiller G., Froestl W., Wolf M.E. In vivo modulation of ventral tegmental area dopamine and glutamate efflux by local GABA(B) receptors is altered after repeated amphetamine treatment. Neuroscience 2002, 109:585-595.
26. González-Maeso J., Wise A., Green A., Koenig J.A. Agonist-induced desensitization and endocytosis of heterodimeric GABAB receptors in CHO-K1 cells. Eur. J. Pharmacol. 2003, 481:15-23.
27. Grace A.A., Bunney B.S. Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity. Brain Res. 1985, 333:271-284.
28. Guetg N., Abdel Aziz S., Holbro N., Turecek R., Rose T., Seddik R., Gassmann M., Moes S., Jenoe P., Oertner T.G., et al. NMDA receptor-dependent GABAB receptor internalization via CaMKII phosphorylation of serine 867 in GABAB1. Proc. Natl. Acad. Sci. USA 2010, 107:13924-13929.
29. Guo H., Reddy S.A., Damuni Z. Purification and characterization of an autophosphorylation-activated protein serine threonine kinase that phosphorylates and inactivates protein phosphatase 2A. J. Biol. Chem. 1993, 268:11193-11198.
30. Henry D.J., Greene M.A., White F.J. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration. J. Pharmacol. Exp. Ther. 1989, 251:833-839.
31. Huang C.S., Shi S.-H., Ule J., Ruggiu M., Barker L.A., Darnell R.B., Jan Y.N., Jan L.Y. Common molecular pathways mediate long-term potentiation of synaptic excitation and slow synaptic inhibition. Cell 2005, 123:105-118.
32. Hyman S.E., Malenka R.C., Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu. Rev. Neurosci. 2006, 29:565-598.
33. Johnson S.W., North R.A. Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J. Physiol. 1992, 450:455-468.
34. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Brain Res. Rev. 1991, 16:223-244.
35. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2010, 35:217-238.
36. Koya E., Uejima J.L., Wihbey K.A., Bossert J.M., Hope B.T., Shaham Y. Role of ventral medial prefrontal cortex in incubation of cocaine craving. Neuropharmacology 2009, 56(Suppl 1):177-185.
37. Koyrakh L., Luján R., Colón J., Karschin C., Kurachi Y., Karschin A., Wickman K. Molecular and cellular diversity of neuronal G-protein-gated potassium channels. J. Neurosci. 2005, 25:11468-11478.
38. Kulik A., Vida I., Luján R., Haas C.A., López-Bendito G., Shigemoto R., Frotscher M. Subcellular localization of metabotropic GABA(B) receptor subunits GABA(B1a/b) and GABA(B2) in the rat hippocampus. J. Neurosci. 2003, 23:11026-11035.
39. B receptors and GIRK channels in dopamine neurons of the ventral tegmental area. Nat. Neurosci. 2007, 10:1559-1568.
40. Lavine N., Ethier N., Oak J.N., Pei L., Liu F., Trieu P., Rebois R.V., Bouvier M., Hebert T.E., Van Tol H.H. G protein-coupled receptors form stable complexes with inwardly rectifying potassium channels and adenylyl cyclase. J. Biol. Chem. 2002, 277:46010-46019.
41. Lehrmann E., Oyler J., Vawter M.P., Hyde T.M., Kolachana B., Kleinman J.E., Huestis M.A., Becker K.G., Freed W.J. Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse. Pharmacogenomics J. 2003, 3:27-40.
42. Liu Q.S., Pu L., Poo M.M. Repeated cocaine exposure in vivo facilitates LTP induction in midbrain dopamine neurons. Nature 2005, 437:1027-1031.
43. Lucchesi W., Mizuno K., Giese K.P. Novel insights into CaMKII function and regulation during memory formation. Brain Res. Bull. 2011, 85:2-8.
44. Lujan R., Nusser Z., Roberts J.D., Shigemoto R., Somogyi P. Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus. Eur. J. Neurosci. 1996, 8:1488-1500.
45. Lüscher C., Slesinger P.A. Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease. Nat. Rev. Neurosci. 2010, 11:301-315.
46. Lüscher C., Malenka R.C. Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron 2011, 69:650-663.
47. Maier P.J., Marin I., Grampp T., Sommer A., Benke D. Sustained glutamate receptor activation down-regulates GABAB receptors by shifting the balance from recycling to lysosomal degradation. J. Biol. Chem. 2010, 285:35606-35614.
48. Mameli M., Bellone C., Brown M.T.C., Lüscher C. Cocaine inverts rules for synaptic plasticity of glutamate transmission in the ventral tegmental area. Nat. Neurosci. 2011, 14:414-416.
49. Manzoni O.J., Williams J.T. Presynaptic regulation of glutamate release in the ventral tegmental area during morphine withdrawal. J. Neurosci. 1999, 19:6629-6636.
50. Morgan A.D., Carroll M.E., Loth A.K., Stoffel M., Wickman K. Decreased cocaine self-administration in Kir3 potassium channel subunit knockout mice. Neuropsychopharmacology 2003, 28:932-938.
51. Nestler E.J., Terwilliger R.Z., Walker J.R., Sevarino K.A., Duman R.S. Chronic cocaine treatment decreases levels of the G protein subunits Gi alpha and Go alpha in discrete regions of rat brain. J. Neurochem. 1990, 55:1079-1082.
52. Nobles M., Benians A., Tinker A. Heterotrimeric G proteins precouple with G protein-coupled receptors in living cells. Proc. Natl. Acad. Sci. USA 2005, 102:18706-18711.
53. Nugent F.S., Penick E.C., Kauer J.A. Opioids block long-term potentiation of inhibitory synapses. Nature 2007, 446:1086-1090.
54. Omelchenko N., Sesack S.R. Ultrastructural analysis of local collaterals of rat ventral tegmental area neurons: GABA phenotype and synapses onto dopamine and GABA cells. Synapse 2009, 63:895-906.
55. Padgett C.L., Slesinger P.A. GABAB receptor coupling to G-proteins and ion channels. Adv Pharmacol. 2010, 58:123-147.
56. Pu L., Liu Q.S., Poo M.M. BDNF-dependent synaptic sensitization in midbrain dopamine neurons after cocaine withdrawal. Nat. Neurosci. 2006, 9:605-607.
57. Riven I., Iwanir S., Reuveny E. GIRK channel activation involves a local rearrangement of a preformed G protein channel complex. Neuron 2006, 51:561-573.
58. Roberts D.C., Koob G.F. Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats. Pharmacol. Biochem. Behav. 1982, 17:901-904.
59. Scibelli A.C., McKinnon C.S., Reed C., Burkhart-Kasch S., Li N., Baba H., Wheeler J.M., Phillips T.J. Selective breeding for magnitude of methamphetamine-induced sensitization alters methamphetamine consumption. Psychopharmacology (Berl) 2011, 214:791-804.
60. Shimosato K., Watanabe S., Kitayama S. Differential effects of trihexyphenidyl on place preference conditioning and locomotor stimulant activity of cocaine and methamphetamine. Naunyn Schmiedebergs Arch. Pharmacol. 2001, 364:74-80.
61. Shoji S., Simms D., McDaniel W.C., Gallagher J.P. Chronic cocaine enhances gamma-aminobutyric acid and glutamate release by altering presynaptic and not postsynaptic gamma-aminobutyric acidB receptors within the rat dorsolateral septal nucleus. J. Pharmacol. Exp. Ther. 1997, 280:129-137.
62. Sulzer D. How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron 2011, 69:628-649.
63. Tamamaki N., Yanagawa Y., Tomioka R., Miyazaki J., Obata K., Kaneko T. Green fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in mouse. J. Comp. Neurol. 2003, 467:60-79.
64. Tan K.R., Brown M., Labouèbe G., Yvon C., Creton C., Fritschy J.-M., Rudolph U., Lüscher C. Neural bases for addictive properties of benzodiazepines. Nature 2010, 463:769-774.
65. Taniyama K., Takeda K., Ando H., Tanaka C. Expression of the GABAB receptor in Xenopus oocytes and desensitization by activation of protein kinase C. Adv. Exp. Med. Biol. 1991, 287:413-420.
66. Terunuma M., Vargas K.J., Wilkins M.E., Ramírez O.A., Jaureguiberry-Bravo M., Pangalos M.N., Smart T.G., Moss S.J., Couve A. Prolonged activation of NMDA receptors promotes dephosphorylation and alters postendocytic sorting of GABAB receptors. Proc. Natl. Acad. Sci. USA 2010, 107:13918-13923.
67. Ungless M.A., Whistler J.L., Malenka R.C., Bonci A. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 2001, 411:583-587.
68. Vardya I., Drasbek K.R., Gibson K.M., Jensen K. Plasticity of postsynaptic, but not presynaptic, GABAB receptors in SSADH deficient mice. Exp. Neurol. 2010, 225:114-122.
69. Wang B., Shaham Y., Zitzman D., Azari S., Wise R.A., You Z.B. Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: a role in stress-induced relapse to drug seeking. J. Neurosci. 2005, 25:5389-5396.
70. White F.J. Synaptic regulation of mesocorticolimbic dopamine neurons. Annu. Rev. Neurosci. 1996, 19:405-436.
71. White F.J., Wang R.Y. Electrophysiological evidence for A10 dopamine autoreceptor subsensitivity following chronic D-amphetamine treatment. Brain Res. 1984, 309:283-292.
72. White F.J., Hu X.T., Zhang X.F., Wolf M.E. Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. J. Pharmacol. Exp. Ther. 1995, 273:445-454.
73. Xi Z.X., Ramamoorthy S., Shen H., Lake R., Samuvel D.J., Kalivas P.W. GABA transmission in the nucleus accumbens is altered after withdrawal from repeated cocaine. J. Neurosci. 2003, 23:3498-3505.
74. Zhang X.F., Hu X.T., White F.J., Wolf M.E. Increased responsiveness of ventral tegmental area dopamine neurons to glutamate after repeated administration of cocaine or amphetamine is transient and selectively involves AMPA receptors. J. Pharmacol. Exp. Ther. 1997, 281:699-706.
75. Zhao S., Maxwell S., Jimenez-Beristain A., Vives J., Kuehner E., Zhao J., O'Brien C., de Felipe C., Semina E., Li M. Generation of embryonic stem cells and transgenic mice expressing green fluorescence protein in midbrain dopaminergic neurons. Eur. J. Neurosci. 2004, 19:1133-1140.